Skip to main content

Ask the News Top News Briefings Markets AI Market Briefs

Watchlist Bookmarks

Ozempic maker sues US rival over ad campaign — Brief24

Ask the News Briefings Top News News Business Sports

Ozempic maker sues US rival over ad campaign

Deutsche Welle+9

qz.com

Novo Nordisk has claimed that Eli Lilly is using bad data to compare the companies' weight-loss and diabetes products in its ads.

Chat about this story

Quick actions

Chat about this story… or type / for commands

Brief24 AI

More coverage of this story

Quartz·1 day ago

Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy

Financial Times·88 days ago

Novo Nordisk sues Eli Lilly over ‘deliberately false’ weight-loss drug ads

MarketWatch·88 days ago

Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market

CNBC·88 days ago

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

CBS·88 days ago

Novo Nordisk sues Eli Lilly, accusing it of false advertising

NBC·89 days ago

Novo Nordisk Sues Eli Lilly Over Weight Loss Drug Advertisement

Yahoo News·89 days ago

Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads

The Wall Street Journal·89 days ago

Novo Sues Rival Lilly Over Alleged False Advertising in Weight-Loss Ads

Yahoo Finance·89 days ago

Novo Nordisk sues Eli Lilly over misleading weight loss drug ads

USD/EUR0.8895-0.42%
USD/GBP0.7502-0.75%
USD/JPY157.98+0.02%
USD/CHF0.8237-0.95%
USD/CAD1.414-0.52%
USD/AUD1.439+0.45%
USD/ILS3.111+0.45%
USD/CNY6.686-0.10%

Last updated 1 day ago

15°

Clear

High 15°

Low 2°

Sun

15°

2°

Mon

16°

4°

Tue

18°

12°

Wed

16°

9°

Thu

18°

8°

S&P 500
7,659.44-1.09%
Nasdaq
26,140.03-2.15%
Dow Jones
52,002.41-0.34%
Russell 2000
2,721.37-1.66%
VIX
20.22+22.84%
DAX
25,622.61+0.95%
Gold
$4,188.40+0.44%
Brent
$109.67+3.54%
Bitcoin
$81,480-0.80%
TA 35
4,224.67+1.64%
TA 125
4,091.37+1.72%
TA Banks-5

Last updated 1 day ago

8,908.43+0.78%